![](/img/cover-not-exists.png)
827 Phase IIA, Randomized, Placebo-Controlled Evaluation of the Efficacy and Safety of Induction Therapy With Eldelumab (Anti-IP-10 Antibody; BMS-936557) in Patients With Active Crohn's Disease
Sandborn, William J., Rutgeerts, Paul J., Colombel, Jean-Frederic, Ghosh, Subrata, Petryka, Robert, Sands, Bruce E., Mitra, Pranab, Luo, AllisonVolume:
148
Language:
english
Journal:
Gastroenterology
DOI:
10.1016/S0016-5085(15)30544-8
Date:
April, 2015
File:
PDF, 996 KB
english, 2015